|
ZNF277 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.247600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.658000E-01 |
| Normal-vs-Stage2 |
9.432400E-01 |
| Normal-vs-Stage3 |
2.132400E-01 |
| Normal-vs-Stage4 |
6.384800E-01 |
| Stage1-vs-Stage2 |
4.776800E-01 |
| Stage1-vs-Stage3 |
7.037800E-01 |
| Stage1-vs-Stage4 |
6.093600E-01 |
| Stage2-vs-Stage3 |
3.885600E-01 |
| Stage2-vs-Stage4 |
7.674000E-01 |
| Stage3-vs-Stage4 |
4.761600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.167800E-01 |
| Normal-vs-AfricanAmerican |
9.609800E-01 |
| Normal-vs-Asian |
1.656950E-01 |
| Caucasian-vs-AfricanAmerican |
4.167000E-01 |
| Caucasian-vs-Asian |
6.841400E-01 |
| AfricanAmerican-vs-Asian |
2.968800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.515000E-01 |
| Normal-vs-Female |
3.095600E-01 |
| Male-vs-Female |
7.439000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.611200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.583800E-01 |
| Normal-vs-Age(61-80Yrs) |
4.408600E-01 |
| Normal-vs-Age(81-100Yrs) |
2.054800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.152000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.565200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.671600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.235200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.369400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.620600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.956200E-01 |
| Classical-VS-Follicular |
8.089800E-01 |
| Classical-VS-Other |
9.253600E-01 |
| Classical-VS-Normal |
4.316400E-01 |
| Tall-VS-Follicular |
6.154200E-01 |
| Tall-VS-Other |
9.173800E-01 |
| Tall-VS-Normal |
8.364000E-01 |
| Follicular-VS-Other |
8.903800E-01 |
| Follicular-VS-Normal |
4.544400E-01 |
| Other-VS-Normal |
8.312400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.401620E-01 |
| Normal-vs-N1 |
1.933040E-01 |
| N0-vs-N1 |
8.943400E-01 |
|
|
